Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Magerl

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
Experimental Dermatology|March 12, 2008
Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cellsMarkus Magerl, Verena Lammel, Frank Siebenhaar, et al.
Clinical and Translational Allergy|September 25, 2023
Patient-physician interactions in hereditary angioedema-Key learnings from the coronavirus disease 2019 pandemicMarcus Maurer, Thomas Buttgereit, Markus Magerl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 20, 2023
Significant response to berotralstat in 3 patients with hereditary angioedema of unknown originThomas Buttgereit, Stefania Nicola, Carolina Vera, et al.
Allergy and Asthma Proceedings|January 18, 2017
Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidaseKarsten Weller, Marcus Maurer, Moshe Fridman, et al.
Mycoses|September 17, 2008
Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common mouldsPetra Staubach, Anneke Vonend, Gerhard Burow, et al.
Experimental Dermatology|July 23, 2008
Mast cells determine the magnitude of bacterial toxin-induced skin inflammationMartin Metz, Markus Magerl, Nele F Kühl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2023
Hereditary Angioedema: A Review of the Current and Evolving Treatment LandscapeStephen D Betschel, Aleena Banerji, Paula J Busse, et al.
Allergy|August 29, 2023
Patient-level indirect treatment comparison of lanadelumab versus pdC1-INH i.v. in hereditary angioedema patients: PATCH studyMarkus Magerl, Guido Schiffhorst, Lena Fanter, et al.
Clinical and Translational Allergy|September 25, 2023
Could it be hereditary angioedema?-Perspectives from different medical specialtiesMarkus Magerl, Anna Sala-Cunill, Christina Weber-Chrysochoou, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 30, 2026
Garadacimab for the long-term prophylaxis of hereditary angioedemaEmel Aygören-Pürsün, Regina Treudler, Petra Staubach, et al.
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
Experimental Dermatology|March 12, 2008
Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cellsMarkus Magerl, Verena Lammel, Frank Siebenhaar, et al.
Clinical and Translational Allergy|September 25, 2023
Patient-physician interactions in hereditary angioedema-Key learnings from the coronavirus disease 2019 pandemicMarcus Maurer, Thomas Buttgereit, Markus Magerl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 20, 2023
Significant response to berotralstat in 3 patients with hereditary angioedema of unknown originThomas Buttgereit, Stefania Nicola, Carolina Vera, et al.
Allergy and Asthma Proceedings|January 18, 2017
Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidaseKarsten Weller, Marcus Maurer, Moshe Fridman, et al.
Mycoses|September 17, 2008
Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common mouldsPetra Staubach, Anneke Vonend, Gerhard Burow, et al.
Experimental Dermatology|July 23, 2008
Mast cells determine the magnitude of bacterial toxin-induced skin inflammationMartin Metz, Markus Magerl, Nele F Kühl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2023
Hereditary Angioedema: A Review of the Current and Evolving Treatment LandscapeStephen D Betschel, Aleena Banerji, Paula J Busse, et al.
Allergy|August 29, 2023
Patient-level indirect treatment comparison of lanadelumab versus pdC1-INH i.v. in hereditary angioedema patients: PATCH studyMarkus Magerl, Guido Schiffhorst, Lena Fanter, et al.
Clinical and Translational Allergy|September 25, 2023
Could it be hereditary angioedema?-Perspectives from different medical specialtiesMarkus Magerl, Anna Sala-Cunill, Christina Weber-Chrysochoou, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 30, 2026
Garadacimab for the long-term prophylaxis of hereditary angioedemaEmel Aygören-Pürsün, Regina Treudler, Petra Staubach, et al.
Pageof 16